The DOI matches its Crossref record; 133 of the 133 references it cites were found in a registry or an index.
Loss of N-glycolylneuraminic acid in humans: Mechanisms, consequences, and implications for hominid evolution
Open accessAbstract
The surface of all mammalian cells is covered with a dense and complex array of sugar chains, which are frequently terminated by members of a family of molecules called sialic acids. One particular sialic acid called N-glycolylneuraminic acid (Neu5Gc) is widely expressed on most mammalian tissues, but is not easily detectable on human cells. In fact, it provokes an immune response in adult humans. The human deficiency of Neu5Gc is explained by an inactivating mutation in the gene encoding CMP-N-acetylneuraminic acid hydroxylase, the rate-limiting enzyme in generating Neu5Gc in cells of other mammals. This deficiency also results in an excess of the precursor sialic acid N-acetylneuraminic acid (Neu5Ac) in humans. This mutation appears universal to modern humans, occurred sometime after our last common ancestor with the great apes, and happens to be one of the first known human-great ape genetic differences with an obvious biochemical readout. While the original selection mechanisms and major biological consequences of this human-specific mutation remain uncertain, several interesting clues are currently being pursued. First, there is evidence that the human condition can explain differences in susceptibility or resistance to certain microbial pathogens. Second, the functions of some endogenous receptors for sialic acids in the immune system may be altered by this difference. Third, despite the lack of any obvious alternate pathway for synthesis, Neu5Gc has been reported in human tumors and possibly in human fetal tissues, and traces have even been detected in normal human tissues. One possible explanation is that this represents accumulation of Neu5Gc from dietary sources of animal origin. Finally, a markedly reduced expression of hydroxylase in the brains of other mammals raises the possibility that the human-specific mutation of this enzyme could have played a role in human brain evolution.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“CMAH enzyme hydroxylates Neu5Ac to synthesize N-glycolylneuraminic acid (Neu5Gc), which is a modified sialic acid that is widely expressed in most mammalian cells but not in humans”
From ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies (2023) · cites this paper as Varki, 2001
In the citing paper
“Environmental exposure to Neu5Gc, such as the consumption of red meat, which is rich in Neu5Gc, can result in its incorporation into human glycans”
From ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies (2023) · cites this paper as Varki, 2001
In the citing paper
“CMAH is a pseudogene.”
From ABO blood group antigens and differential glycan expression: Perspective on the evolution of common human enzyme deficiencies (2023) · cites this paper as Varki, 2001
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Initial sequencing and analysis of the human genome
International Human Genome Sequencing Consortium, Whitehead Institute for Biomedical Research, C. F. G. R., Lander, E. S., Linton, L. M., Birren, B., Nusbaum, C., Zody, M. C., Baldwin, J., Devon, K., Dewar, K., et al. (2001) · Nature · doi:10.1038/35057062 · Cited by 24,216 · cited 2×
“A third limitation of the DNA-RNA-protein paradigm for explaining humans is that the human genome seems to have less than 35,000 genes (Lander et al., 2001; Venter et al., 2001) .”
The sequence of the human genome
Venter, J. C., Adams, M. D., Myers, E. W., Li, P. W., Mural, R. J., Sutton, G. G., Smith, H. O., Yandell, M., Evans, C. A., Holt, R. A., et al. (2001) · Science · doi:10.1126/science.1058040 · Cited by 13,909
King, M.-C., & Wilson, A. C. (1975) · Science · doi:10.1126/science.1090005 · Cited by 2,815
Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolution
Wilson, I. A., Skehel, J. J., & Wiley, D. C. (1981) · Nature · doi:10.1038/289366a0 · Cited by 2,525
Selectins and their ligands: Current concepts and controversies
Kansas, G. (1996) · Blood · doi:10.1182/blood.v88.9.3259.bloodjournal8893259 · Cited by 1,415
Neandertal DNA Sequences and the Origin of Modern Humans
Krings, M., Stone, A., Schmitz, R. W., Krainitzki, H., Stoneking, M., & Pääbo, S. (1997) · Cell · doi:10.1016/s0092-8674(00)80310-4 · Cited by 1,324
Structure of the influenza virus haemagglutinin complexed with its receptor, sialic acid
Weis, W., Brown, J. H., Cusack, S., Paulson, J. C., Skehel, J. J., & Wiley, D. C. (1988) · Nature · doi:10.1038/333426a0 · Cited by 1,158
Rademacher, T. W., Parekh, R. B., & Dwek, R. A. (1988) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.57.070188.004033 · Cited by 1,148
van Die, I. (2017) · Pure Amsterdam UMC · Cited by 1,112
Varki, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.16.7390 · Cited by 946 · cited 2×
“…are also recognized by specific receptors within the same animals that synthesize these sugars (Bevilacqua and Nelson, 1993; Kelm et al., 1994b; Varki, 1994, 1997; Powell and Varki, 1995; Crocker and Feizi, 1996; Kansas, 1996; Collins et al., 1997a; Kelm and Schauer, 1997; Crocker et al.,…”
BackgroundSelf-citation
Research works printed but not linked: 33
- Andrews, 1992, Blood, 79, 2485, 10.1182/blood.V79.9.2485.2485 · doi:10.1182/blood.v79.9.2485.2485
- Angata, 2001, Chem Rev
- Bouhours, 1989, J Biol Chem, 264, 16992, 10.1016/S0021-9258(18)71449-X · doi:10.1016/s0021-9258(18)71449-x
- Bozue, 1999, J Biol Chem, 274, 4106, 10.1074/jbc.274.7.4106 · doi:10.1074/jbc.274.7.4106
- Chatterji, 2000, Mol Cell Biochem, 215, 47, 10.1023/A:1026582715752 · doi:10.1023/a:1026582715752
- Crocker, 1998, Glycobiology, 8
- Deodhar, 1986, Transplant Proc, 18, 83
- Devine, 1991, Cancer Res, 51, 5826
- Escalante, 1995, Mol Biol Evol, 12, 616
- Furukawa, 1988a, J Biol Chem, 263, 14939, 10.1016/S0021-9258(18)68129-3 · doi:10.1016/s0021-9258(18)68129-3
- Higashi, 1984, Gann, 75, 1025
- Hirabayashi, 1987a, Jpn J Cancer Res, 78, 614
- Hirabayashi, 1987b, Jpn J Cancer Res, 78, 251
- Ikuta, 1982, Biken J, 25, 47
- Ito, 2000, J Virol, 74, 9300, 10.1128/JVI.74.19.9300-9305.2000 · doi:10.1128/jvi.74.19.9300-9305.2000
- Kasukawa, 1976, Clin Exp Immunol, 25, 122
- Kawai, 1991, Cancer Res, 51, 1242
- Lanne, 1995, Biochemistry, 34, 1845, 10.1021/bi00006a004 · doi:10.1021/bi00006a004
- Marquina, 1996, Cancer Res, 56, 5165
- McConkey, 1997, Trends Genet, 13, 350, 10.1016/S0168-9525(97)01226-2 · doi:10.1016/s0168-9525(97)01226-2
- Muchmore, 1998, Am J Phys Anthropol, 107, 187, 10.1002/(SICI)1096-8644(199810)107:2<187::AID-AJPA5>3.0.CO;2-S · doi:10.1002/(sici)1096-8644(199810)107:2<187::aid-ajpa5>3.0.co;2-s
- Ouadia, 1992, Glycoconjugate J, 9, 21, 10.1007/BF00731174 · doi:10.1007/bf00731174
- Reemtsma, 1989, Transplant Proc, 21, 517
- Rutishauser, 1996, Trends Neurosci, 19, 422, 10.1016/S0166-2236(96)10041-2 · DOI
- 1982. Sialic acids: chemistry, metabolism and function, cell biology monographs, volume 10. New York: Springer-Verlag.
- Schwegmann, 2001, Virus Res, 75, 69, 10.1016/S0168-1702(01)00228-3 · doi:10.1016/s0168-1702(01)00228-3
- Shaw, 1994, Eur J Biochem, 219, 1001, 10.1111/j.1432-1033.1994.tb18583.x · doi:10.1111/j.1432-1033.1994.tb18583.x
- Stacker, 1985, J Natl Cancer Inst, 75, 801, 10.1093/jnci/75.5.801 · doi:10.1093/jnci/75.5.801
- Suzuki, 1997, FEBS Lett, 404, 192, 10.1016/S0014-5793(97)00127-0 · doi:10.1016/s0014-5793(97)00127-0
- Takiguchi, 1984, Clin Exp Immunol, 56, 345
- Tettamanti, 1965, Nature, 206, 192, 10.1038/206192a0 · doi:10.1038/206192a0
- Willemsen, 1993, Infect Immun, 61, 4518, 10.1128/IAI.61.10.4518-4522.1993 · doi:10.1128/iai.61.10.4518-4522.1993
- Ye, 1994, Methods Enzymol, 230, 460, 10.1016/0076-6879(94)30029-1 · doi:10.1016/0076-6879(94)30029-1
Cited by
Of Mice and Not Men: Differences between Mouse and Human Immunology
Mestas, J., & Hughes, C. C. W. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.5.2731 · Cited by 3,822
Human embryonic stem cells express an immunogenic nonhuman sialic acid
Martin, M. J., Muotri, A., Gage, F., & Varki, A. (2005) · Nature Medicine · doi:10.1038/nm1181 · Cited by 932
Self-citationGlycan-based interactions involving vertebrate sialic-acid-recognizing proteins
Varki, A. (2007) · Nature · doi:10.1038/nature05816 · Cited by 853
Self-citationDiversity of Microbial Sialic Acid Metabolism
Vimr, E. R., Kalivoda, K. A., Deszo, E. L., & Steenbergen, S. M. (2004) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.68.1.132-153.2004 · Cited by 579
Siglecs—the major subfamily of I-type lectins
Varki, A., & Angata, T. (2006) · Glycobiology · doi:10.1093/glycob/cwj008 · Cited by 518
Self-citationDiversity in cell surface sialic acid presentations: implications for biology and disease
Varki, N. M., & Varki, A. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700656 · Cited by 515
Self-citationSialic acids in cancer biology and immunity
Pearce, O. M. T., & Läubli, H. (2016) · Glycobiology · doi:10.1093/glycob/cwv097 · Cited by 470
Sialic acids: fascinating sugars in higher animals and man
Schauer, R. (2004) · Zoology · doi:10.1016/j.zool.2003.10.002 · Cited by 413
Sialic Acid Is an Essential Nutrient for Brain Development and Cognition
Wang, B. (2009) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155515 · Cited by 362
Padler-Karavani, V., Yu, H., Cao, H., Chokhawala, H., Karp, F., Varki, N., Chen, X., & Varki, A. (2008) · Glycobiology · doi:10.1093/glycob/cwn072 · Cited by 326
Self-citationGhaderi, D., Zhang, M., Hurtado-Ziola, N., & Varki, A. (2012) · Biotechnology and Genetic Engineering Reviews · doi:10.5661/bger-28-147 · Cited by 320
“Meanwhile, human biosynthetic pathways could theoretically allow exogenous Neu5Gc to be metabolically incorporated (Varki, 2001; Oetke et al., 2001).”
BackgroundSelf-citationThe life and death of gene families
Demuth, J. P., & Hahn, M. W. (2009) · BioEssays · doi:10.1002/bies.080085 · Cited by 311
Microbial recognition of human cell surface glycoconjugates
Imberty, A., & Varrot, A. (2008) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2008.08.001 · Cited by 307
Metabolic glycoengineering: Sialic acid and beyond
Du, J., Meledeo, M. A., Wang, Z., Khanna, H. S., Paruchuri, V. D. P., & Yarema, K. J. (2009) · Glycobiology · doi:10.1093/glycob/cwp115 · Cited by 299
Lutz, A. J., Li, P., Estrada, J. L., Sidner, R. A., Chihara, R. K., Downey, S. M., Burlak, C., Wang, Z., Reyes, L. M., Ivary, B., et al. (2013) · Xenotransplantation · doi:10.1111/xen.12019 · Cited by 294
The influence of evolutionary history on human health and disease
Benton, M. L., Abraham, A., LaBella, A. L., Abbot, P., Rokas, A., & Capra, J. A. (2021) · Nature Reviews Genetics · doi:10.1038/s41576-020-00305-9 · Cited by 291
Gene Losses during Human Origins
Wang, X., Grus, W. E., & Zhang, J. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040052 · Cited by 246
“consequences to human biology and evolution [28].”
Loss of Siglec expression on T lymphocytes during human evolution
Nguyen, D. H., Hurtado-Ziola, N., Gagneux, P., & Varki, A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510484103 · Cited by 204
Self-citationEmergence and significance of carbohydrate-specific antibodies
Kappler, K., & Hennet, T. (2020) · Genes & Immunity · doi:10.1038/s41435-020-0105-9 · Cited by 118
Jajosky, R. P., Wu, S.-C., Zheng, L., Jajosky, A. N., Jajosky, P. G., Josephson, C. D., Hollenhorst, M. A., Sackstein, R., Cummings, R. D., Arthur, C. M., et al. (2023) · iScience · doi:10.1016/j.isci.2022.105798 · Cited by 110
Glycosylated Biotherapeutics: Immunological Effects of N-Glycolylneuraminic Acid
Yehuda, S., & Padler-Karavani, V. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00021 · Cited by 71
Glycoengineering in CHO cells: advances in systems biology
Tejwani, V., Andersen, M. R., Nam, J. H., & Sharfstein, S. T. (2018) · Biotechnology Journal · doi:10.1002/biot.201700234 · Cited by 70
Wang, Z., Burlak, C., Estrada, J. L., Li, P., Tector, M. F., & Tector, A. J. (2014) · Xenotransplantation · doi:10.1111/xen.12106 · Cited by 64
“Similar to aGal, Neu5Gc is absent on human cells and has been defined as a non-Gal antigen target on human erythrocytes recognized by human preformed antibodies [6,10].”
BackgroundIto, M., Sugihara, K., Asaka, T., Toyama, T., Yoshihara, T., Furuichi, K., Wada, T., & Asano, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029873 · Cited by 47
“Another possibility is that the molecular Neu5Ac and Neu5Gc sialic acid species might function differently in humans and mice, since humans, but not mice, are genetically defective in synthesizing Neu5Gc, a common mammalian sialic acid [34].”
Ashwood, C., Waas, M., Weerasekera, R., & Gundry, R. L. (2020) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2019.12.012 · Cited by 25
GLADX: an automated approach to analyze the lineage-specific loss and pseudogenization of genes
Dainat, J., Paganini, J., Pontarotti, P., & Gouret, P. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038792 · Cited by 9
Metadata
- Authors
- Varki, A.
- Venue
- American Journal of Physical Anthropology
- Publisher
- Wiley
- Published
- 2001
- Volume
- 116
- Issue
- S33
- Pages
- 54-69
- ISSN
- 0002-9483 (ISSN-L)
- 1096-8644
- OpenAlex
- W4243603314
- Cited by
- 324
- References
- 133
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- Licence
- doi.wiley.com/10.1002/tdm_license_1.1 (tdm, 5356 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.